- Home
- PINC vs TWST Comparison
PINC vs TWST Comparison
Compare PINC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- TWST
- Stock Information
- Founded
- PINC 2013
- TWST 2013
- Country
- PINC United States
- TWST United States
- Employees
- PINC N/A
- TWST N/A
- Industry
- PINC Other Consumer Services
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PINC Consumer Discretionary
- TWST Health Care
- Exchange
- PINC Nasdaq
- TWST Nasdaq
- Market Cap
- PINC 1.9B
- TWST 1.8B
- IPO Year
- PINC 2013
- TWST 2018
- Fundamental
- Price
- PINC $21.51
- TWST $36.40
- Analyst Decision
- PINC Hold
- TWST Buy
- Analyst Count
- PINC 6
- TWST 10
- Target Price
- PINC $22.20
- TWST $49.10
- AVG Volume (30 Days)
- PINC 1.6M
- TWST 1.1M
- Earning Date
- PINC 08-19-2025
- TWST 08-01-2025
- Dividend Yield
- PINC 3.88%
- TWST N/A
- EPS Growth
- PINC N/A
- TWST N/A
- EPS
- PINC 0.63
- TWST N/A
- Revenue
- PINC $1,260,388,000.00
- TWST $347,680,000.00
- Revenue This Year
- PINC N/A
- TWST $22.58
- Revenue Next Year
- PINC N/A
- TWST $17.71
- P/E Ratio
- PINC $34.18
- TWST N/A
- Revenue Growth
- PINC 7.16
- TWST 25.30
- 52 Week Low
- PINC $17.23
- TWST $27.12
- 52 Week High
- PINC $23.56
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- PINC 37.41
- TWST 61.25
- Support Level
- PINC $21.99
- TWST $34.85
- Resistance Level
- PINC $22.21
- TWST $37.72
- Average True Range (ATR)
- PINC 0.48
- TWST 1.79
- MACD
- PINC -0.17
- TWST 0.49
- Stochastic Oscillator
- PINC 20.65
- TWST 85.91
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.